Industry Briefs: June 18, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Amgen has completed its acquisition of the Turkish company, Mustafa Nevzat Pharmaceuticals. Read More
Dalton Pharma Services and Clarity Pharmaceuticals have entered into a manufacturing-services agreement under which Dalton Pharma Services will provide cGMP chemistry manufacturing, scale-up, aseptic fill–finish services, and analytical support for Clarity’s positron emission tomography-based companion diagnostics and radio-immunotherapeutics development program. Read More
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM has signed a commercial agreement for contract manufacturing services using its proprietary XD high cell-density process technology with an undisclosed pharmaceutical company. Read More
In other news, Royal DSM’s tender offer to purchase all outstanding shares of common stock of the medical-device company Kensey Nash at a price of $38.50 per share was successful. Read More
Frazier Healthcare has acquired Catalent Pharma Solutions's US commercial pharmaceutical-packaging operations, based in Philadelphia, Pennsylvania, and Woodstock, Illinois. Read More
JDRF and Novo Nordisk have established an R&D collaboration for disease-modifying immunotherapies for Type I diabetes. Read More
Merck & Co. and Ambrx have agreed to design and develop rationally optimized biologic drug conjugates based on Ambrx’s site-specific protein medicinal chemistry technology. Read More
Roche’s Genentech has entered into a CHF 400-million ($418 million) agreement with AC Immune for developing anti-Tau antibodies for treating Alzheimer’s disease. Read More
Unilife has entered into a seven-year commercial supply contract with an undisclosed pharmaceutical company for the use of its Unifill prefilled syringe. Read More
Waters has began construction on its new mass spectrometry headquarters in Wilmslow, United Kingdom. Read More
People News
AMRI has appointed Srinivas Nanduri as director of medicinal chemistry at the company’s research center in Hyderabad, India, reporting to Subramanyam Maddala, president of AMRI’s India operations. In addition, Suneel Kumar Bommisetty was named senior research associate of computational chemistry, reporting to Nanduri. Read More
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
